OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
Liang Tao, Xinquan Yang, Chaodong Ge, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2190-2206.e5
Open Access | Times Cited: 14

Showing 14 citing articles:

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 38

Redox Imbalance Drives Magnetic Property and Function Changes in Mice
Chuanlin Feng, Lei Zhang, Xiaoyuan Zhou, et al.
Redox Biology (2025) Vol. 81, pp. 103561-103561
Open Access

Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access

Research Progress on the Prevention and Treatment of Atherosclerosis Based on the Mechanism of Ferroptosis
振兴 史
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 958-966
Closed Access

Adipocyte-derived ferroptotic signaling mitigates obesity
Xue Wang, Qian Wu, Minling Zhong, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 4

Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
Ruoxuan Ni, Jianwei Jiang, Fudi Wang, et al.
Science China Life Sciences (2025)
Closed Access

Ferroptosis in adipose tissue: A promising pathway for treating obesity?
John R. Speakman
Cell Metabolism (2025) Vol. 37, Iss. 3, pp. 560-561
Closed Access

Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis
Linjing Long, Yue Wu, Huijun Tang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Ochratoxin A-induced mitochondrial pathway apoptosis and ferroptosis by promoting glycolysis.
Yao Zhou, Wen‐Ying Chen, Shiyu Feng, et al.
PubMed (2025)
Closed Access

Research Progress on the Regulatory Role of Different Cell Death Pathways in Metabolic-dysfunction-associated Steatotic Liver Disease
Congyue Zhang, Mengjiao Sun, Yanbing Ding, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102578-102578
Closed Access

Ironing out MAFLD: Therapeutic targeting of liver ferroptosis
Tuo Shao, Raymond T Chung
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2167-2169
Closed Access | Times Cited: 2

Roles of ferroptosis in the development of diabetic nephropathy
Pan Liu, Zhengdong Zhang, Chen Qiu
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 6, pp. 708-714
Closed Access

Ferroptosis and liver diseases
Xin Li, Liang Tao, Margaret B. Zhong, et al.
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 6, pp. 747-755
Closed Access

[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells
Pan Zhao, Zihui Zhou, Liang Yu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2131-2136
Closed Access

Page 1

Scroll to top